The pivotal trials are STEP (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
Higher Wegovy dose may be considered for individuals who meet specific clinical criteria and have already progressed through the treatment pathway safely
NP: bioanalytical method development and validation
Symptoms such as nausea, breast tenderness, and fatigue can occur for various reasons unrelated to pregnancy
The effect of a L-carnitine supplemented soybean formula on the plasma lipids of infants
This creates a natural 7-day gap that aligns with both drugs' weekly dosing cycles